Polatuzumab vedotin to treat relapsed or refractory diffuse large B-cell lymphoma, in combination with bendamustine plus rituximab. - Amaya ML; Jimeno A; Kamdar M (Drugs of today (Barcelona, Spain : 1998), 2020)